லோ விலக்கு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share:
Jianshun Biosciences Co., Ltd. ( JS Bio ) recently announced its strategic partnership with Etta Biotech Co., Ltd. ( Etta Biotech ), to set up a high titer transient protein expression platform for high quality protein production using JS Bio s transient transfection media. JS Bio becomes the exclusive cell culture supplier for Etta Biotech s transient transfection high titer protein expression platform.
Dr. Edward Dai, Chairman and CEO of Etta Biotech (left); Dr. Luo Shun, Chairman and President of JS Bio (right) (Photo: Business Wire)
Etta Biotech is a leading cell electroporation technology and equipment supplier. Its proprietary large-capacity flow electroporator, X-Porator F1, is one of the only two products of its kind in the world, and leads the market with its outstanding performance and customer value. Etta Biotech s F1 equipment, paired with a completed process optimization protocol, can significantly increase protein expression titer and quality with ....

Luo Shun , Thousand Oaks , United States , Edward Dai , Ettax Porator , Oaks Biopharma , Mettaforge Therapeutics Inc , Etta Biotech Co Ltd , Oaks Biopharmaceuticals Co Ltd , Jianshun Biosciences Co Ltd , Etta Biotech , Business Wire , Vitro Diagnostics , Shun Luo , Thousand Oaks Biopharma , Suzhou Industrial Park , Mayo Clinic , Mettaforge Therapeutics , Haimen Phase , லோ விலக்கு , ஆயிரம் ஓக்ஸ் , ஒன்றுபட்டது மாநிலங்களில் , எட்வர்ட் தாய் , ஏத்த பயோடெக் இணை லிமிடெட் , ஓக்ஸ் உயிர் மருந்துகள் இணை லிமிடெட் , ஏத்த பயோடெக் ,